NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

59 hedge funds and large institutions have $533M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+8
Holders Change %
+15.69%
% of All Funds
1.17%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
13
Increased
32
Reduced
8
Closed
5
Calls
Puts
Net Calls
Net Calls Change